Opportunity Information: Apply for W81XWH 10 LCRP LCEDCC

  • The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DOD Lung Cancer Early Detection Clinical Consortium Award" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
  • This funding opportunity was created on Sep 3, 2010 and posted on Sep 3, 2010.
  • Applicants must submit their applications by Dec 7, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $13,500,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Apply for W81XWH 10 LCRP LCEDCC

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The DOD Lung Cancer Early Detection Clinical Consortium Award (Funding Opportunity Number W81XWH-10-LCRP-LCEDCC) is a Fiscal Year 2010 funding opportunity from the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA), under the Lung Cancer Research Program (LCRP). It is a discretionary, science and technology/research and development award made as a cooperative agreement, meaning the government expects to have substantial involvement during the project period rather than operating strictly as a hands-off grant. This mechanism was offered for the first time in FY2010 and is aimed specifically at supporting clinical research that can improve how lung cancer is detected early, with the larger goal of improving patient outcomes.

The core purpose of the award is to fund clinical studies that characterize, develop, and/or improve early detection modalities for lung cancer. In practice, this is meant to move beyond basic discovery and focus on patient-centered research that can generate evidence strong enough to influence real-world screening or diagnostic approaches. The program emphasizes building a multi-institutional clinical consortium that intentionally links military and civilian capabilities: it seeks to bring together (1) military beneficiaries who are at high risk for developing lung cancer and lung cancer patients treated at specified military treatment facilities (MTFs) and (2) the patient populations, specialized tools, and scientific expertise available at strong civilian research organizations. A major expected outcome is not just study results, but also the creation of a durable clinical infrastructure for an ongoing early detection program that can continue beyond the end of the award.

Projects proposed under this award are expected to be militarily relevant and methodologically rigorous. The announcement highlights several expectations that signal a focus on high-quality clinical evidence: proposals should have clear, well-defined objectives; they should control for confounding factors; and they should include access to a patient population large enough to deliver adequate statistical power. The studies should also be designed with an eye toward impact, specifically the likelihood of producing results that could change clinical practice for early detection of lung cancer. If any portion of the work involves non-military patient populations, applicants must explicitly explain how those populations and findings relate back to the targeted communities, namely Armed Forces members and/or the U.S. veteran population.

The allowable scope is limited strictly to clinical research and clinical trials, including multi-site consortium studies that may range from small randomized or pilot clinical trials to large randomized clinical trials. Preclinical work is not the focus here, and animal studies are explicitly excluded from consideration. In other words, the award is built for investigators who are ready to test or validate early detection strategies in humans, within a structured clinical consortium setting, and with enough scale and rigor to yield clinically meaningful conclusions.

From an administrative standpoint, the opportunity anticipated a single award, with an estimated total funding amount of $13,500,000 and no cost sharing or matching requirement. Eligibility was listed as unrestricted (open to any type of entity), subject to any additional eligibility clarifications contained in the full announcement. The opportunity was posted on September 3, 2010, with an original and final closing date of December 7, 2010, and an archive date of January 6, 2011. The CFDA listing associated with the program is 12.420 (Military Medical Research and Development). For assistance, the announcement provided contacts for accessing the full posting (PA HELP at 301-619-7079 or cdmrp.pa@amedd.army.mil) and for electronic submission support (eReceipt HELP at 301-682-5507 or help@cdmrp.org), along with the CDMRP Help Desk.

Frequently Asked Questions (FAQs)

What is the DOD Lung Cancer Early Detection Clinical Consortium Award?

It is a Fiscal Year 2010 funding opportunity from the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA), offered under the Lung Cancer Research Program (LCRP). The opportunity is titled the Lung Cancer Early Detection Clinical Consortium Award and is identified by Funding Opportunity Number W81XWH-10-LCRP-LCEDCC.

What is the main goal of this funding opportunity?

The core purpose is to fund clinical studies that characterize, develop, and/or improve early detection modalities for lung cancer, with the broader aim of improving patient outcomes. The emphasis is on patient-centered clinical research intended to generate evidence that could influence real-world screening or diagnostic approaches.

What type of award mechanism is being used?

This opportunity is offered as a cooperative agreement. That means the government expects to have substantial involvement during the project period, rather than operating as a strictly hands-off grant.

Is this award focused on basic research or clinical research?

The allowable scope is limited strictly to clinical research and clinical trials in humans. The intent is to move beyond basic discovery and support studies that can produce clinically meaningful conclusions about early detection approaches.

Are clinical trials allowed under this opportunity?

Yes. The scope includes clinical research and clinical trials, including multi-site consortium studies. Studies may range from small randomized or pilot clinical trials to large randomized clinical trials.

Are animal studies or other preclinical work allowed?

No. Animal studies are explicitly excluded from consideration, and preclinical work is not the focus of this opportunity.

What is meant by a "clinical consortium" in this opportunity?

The program emphasizes building a multi-institutional clinical consortium designed to link military and civilian capabilities. The consortium is expected to connect military beneficiaries at high risk for lung cancer and lung cancer patients treated at specified military treatment facilities (MTFs) with patient populations, specialized tools, and scientific expertise available at strong civilian research organizations.

What is a major expected outcome besides study results?

A major expected outcome is the creation of a durable clinical infrastructure for an ongoing early detection program that can continue beyond the end of the award, in addition to the clinical findings generated by the funded studies.

What populations is the program intended to serve?

The opportunity is intended to link and leverage: (1) military beneficiaries who are at high risk for developing lung cancer and lung cancer patients treated at specified military treatment facilities (MTFs), and (2) the broader patient populations and research strengths available at civilian research organizations.

Does the proposal need to demonstrate military relevance?

Yes. Projects are expected to be militarily relevant. If any portion of the work involves non-military patient populations, the application must explicitly explain how those populations and findings relate back to Armed Forces members and/or the U.S. veteran population.

What research quality expectations are highlighted in the announcement?

The announcement emphasizes methodologically rigorous clinical research. Examples of stated expectations include clear, well-defined objectives; controlling for confounding factors; and access to a patient population large enough to provide adequate statistical power.

What does the program mean by aiming for "impact" on clinical practice?

Studies should be designed with an eye toward producing results likely to change clinical practice for early detection of lung cancer, meaning the research should generate evidence strong enough to influence screening or diagnostic approaches in real-world settings.

How many awards were anticipated?

The opportunity anticipated a single award.

What was the estimated total funding available?

The estimated total funding amount was $13,500,000.

Is cost sharing or matching required?

No. The announcement states there is no cost sharing or matching requirement.

Who was eligible to apply?

Eligibility was listed as unrestricted (open to any type of entity), subject to any additional eligibility clarifications in the full announcement.

When was the opportunity posted?

The opportunity was posted on September 3, 2010.

What were the application deadlines?

The original and final closing date listed for the opportunity was December 7, 2010.

When was the opportunity archived?

The archive date was January 6, 2011.

What CFDA program is associated with this opportunity?

The CFDA listing associated with the program is 12.420 (Military Medical Research and Development).

Which agency and office administered this opportunity?

The opportunity is from the Department of the Army and administered through the U.S. Army Medical Research Acquisition Activity (USAMRAA), under the Lung Cancer Research Program (LCRP).

What is the best way to get help accessing the full posting?

For assistance accessing the full posting, the announcement lists PA HELP at 301-619-7079 or cdmrp.pa@amedd.army.mil.

Who can help with electronic submission issues?

For electronic submission support, the announcement lists eReceipt HELP at 301-682-5507 or help@cdmrp.org, along with the CDMRP Help Desk.

Was this award mechanism new at the time?

Yes. The announcement states that this mechanism was offered for the first time in FY2010.

What kinds of institutions are expected to participate in the consortium?

The announcement emphasizes a multi-institutional structure linking military treatment facilities (MTFs) and military beneficiaries with strong civilian research organizations that provide patient populations, specialized tools, and scientific expertise.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: Utah Prairie Dog Recovery Implementation Coordinator Position

Previous opportunity: Cooperative Agreement, NPS/MTFWP

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 10 LCRP LCEDCC

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 10 LCRP LCEDCC) also looked into and applied for these:

Funding Opportunity
Accelerating Innovation Research Apply for 10 608

Funding Number: 10 608
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: $1,000,000
Broadening Participation Research Initiation Grants in Engineering Apply for 10 609

Funding Number: 10 609
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: $175,000
Tahoe Research Supported by SNPLMA Round 11 Apply for USDA FS PSW TAHOE 2010

Funding Number: USDA FS PSW TAHOE 2010
Agency: Forest Service
Category: Science and Technology and other Research and Development
Funding Amount: $800,000
Probability Apply for PD 10 1263

Funding Number: PD 10 1263
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Discovery Research K 12 Apply for 10 610

Funding Number: 10 610
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Comparative Analysis of Marine Ecosystem Organization Apply for 10 611

Funding Number: 10 611
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Strategic Technologies Apply for DARPA BAA 10 83

Funding Number: DARPA BAA 10 83
Agency: Defense Advanced Research Projects Agency
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
FY 2010 Railroad Safety Program Risk Reduction Program Apply for FR RSR 10 004

Funding Number: FR RSR 10 004
Agency: DOT/Federal Railroad Administration
Category: Science and Technology and other Research and Development
Funding Amount: $73,000
Algebra and Number Theory Apply for PD 10 1264

Funding Number: PD 10 1264
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Dynamics of Coupled Natural and Human Systems Apply for 10 612

Funding Number: 10 612
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: $1,500,000
CHE DMR DMS Solar Energy Initiative Apply for 10 613

Funding Number: 10 613
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: $1,750,000
NANOELECTRONICS FOR 2020 AND BEYOND (NEB) Apply for 10 614

Funding Number: 10 614
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Geomechanics Geomaterials Apply for PD 10 1634

Funding Number: PD 10 1634
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
U.S. Nuclear Regulatory Commission, Office of Nuclear Regulatory Research Announcement of Opportunity, Fiscal Years 2011 2012 Apply for RGR FN 0910 RES

Funding Number: RGR FN 0910 RES
Agency: Nuclear Regulatory Commission
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Monitoring and Evaluations Apply for LSRCP NOI 11 J008

Funding Number: LSRCP NOI 11 J008
Agency: Fish and Wildlife Service
Category: Science and Technology and other Research and Development
Funding Amount: $871,978
Promoting Research and Innovation in Methodologies for Evaluation Apply for 10 615

Funding Number: 10 615
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Ecology of Infectious Diseases Apply for 10 616

Funding Number: 10 616
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: $2,500,000
Monitoring and Evaluations Apply for LSRCP NOI 11 J012

Funding Number: LSRCP NOI 11 J012
Agency: Fish and Wildlife Service
Category: Science and Technology and other Research and Development
Funding Amount: $777,195
Monitoring and Evaluations Apply for LSRCP NOI 11 J014

Funding Number: LSRCP NOI 11 J014
Agency: Fish and Wildlife Service
Category: Science and Technology and other Research and Development
Funding Amount: $270,803
Monitoring and Evaluations Apply for LSRCP NOI 11 J015

Funding Number: LSRCP NOI 11 J015
Agency: Fish and Wildlife Service
Category: Science and Technology and other Research and Development
Funding Amount: $350,018

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 10 LCRP LCEDCC", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.